Maxcyte (DI) (MXCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
12 Jun 2024 07:00 AM
RNS
Result of AGM
11 Jun 2024 07:00 AM
RNS
PDMR Dealing
03 Jun 2024 03:22 PM
RNS
Total Voting Rights
29 May 2024 01:05 PM
RNS
Participation in Upcoming Investor Conference
22 May 2024 01:05 PM
RNS
Signing of Strategic Platform License
20 May 2024 07:00 AM
RNS
Holding(s) in Company
14 May 2024 02:55 PM
RNS
Holding(s) in Company
08 May 2024 07:05 AM
RNS
Filing of Form 10-Q
08 May 2024 07:00 AM
RNS
First Quarter Results
03 May 2024 07:00 AM
RNS
Notice of AGM
01 May 2024 05:04 PM
RNS
Total Voting Rights
10 Apr 2024 01:05 PM
RNS
Notice of Results
03 Apr 2024 07:00 AM
RNS
Total Voting Rights and Block Listing Return
02 Apr 2024 01:05 PM
RNS
Signing of Strategic Platform License
02 Apr 2024 07:00 AM
RNS
Exercise of options and PDMR dealing
20 Mar 2024 10:16 AM
RNS
Grant of Options, RSUs and PSUs and PDMR Dealing
20 Mar 2024 10:05 AM
RNS
Grant of Options, RSUs and PSUs and PDMR Dealing
13 Mar 2024 07:05 AM
RNS
Filing of form 10-K for FY ended December 31, 2023
13 Mar 2024 07:00 AM
RNS
Reports Q4 & FY 2023 Financial Results
06 Mar 2024 08:58 AM
RNS
TR-1: Notification of major holdings
05 Mar 2024 07:00 AM
RNS
Preliminary FY Results & 2024 Guidance
01 Mar 2024 05:57 PM
RNS
Total Voting Rights
29 Feb 2024 09:21 AM
RNS
Exercise of options and PDMR dealing
26 Feb 2024 07:00 AM
RNS
TR-1: Notification of major holdings
09 Feb 2024 01:05 PM
RNS
Notice of Results
01 Feb 2024 09:24 AM
RNS
Total Voting Rights
31 Jan 2024 07:00 AM
RNS
Director/PDMR Shareholding
30 Jan 2024 02:29 PM
RNS
Holding(s) in Company
30 Jan 2024 01:05 PM
RNS
Signing of Strategic Platform License
29 Jan 2024 04:52 PM
RNS
TR-1: Notification of major holdings
29 Jan 2024 07:00 AM
RNS
Filing of Form 8-K
23 Jan 2024 01:05 PM
RNS
Signing of Strategic Platform License
09 Jan 2024 07:00 AM
RNS
Preliminary Unaudited Q4 and FY 2023 Results
05 Jan 2024 07:00 AM
RNS
Grant of Options and PDMR Dealing
03 Jan 2024 01:05 PM
RNS
Signing of Strategic Platform License
02 Jan 2024 09:23 AM
RNS
Total Voting Rights
02 Jan 2024 07:00 AM
RNS
Confirmation of Board change
29 Dec 2023 07:00 AM
RNS
Exercise of options and PDMR dealing
12 Dec 2023 07:00 AM
RNS
CEO Transition and Revenue Guidance Update
07 Dec 2023 09:50 AM
RNS
Exercise of options and PDMR dealing
04 Dec 2023 07:00 AM
RNS
Exercise of options and PDMR dealing
01 Dec 2023 05:43 PM
RNS
Total Voting Rights
30 Nov 2023 07:00 AM
RNS
Exercise of options and PDMR dealing
17 Nov 2023 07:00 AM
RNS
Exercise of options and PDMR dealing
16 Nov 2023 01:05 PM
RNS
MaxCyte Joins the Alliance for mRNA Medicines
09 Nov 2023 07:01 AM
RNS
Filing of Form 10-Q
09 Nov 2023 07:00 AM
RNS
Third Quarter Results
07 Nov 2023 07:00 AM
RNS
Participation in Upcoming Investor Conferences
01 Nov 2023 01:12 PM
RNS
Total Voting Rights
05 Oct 2023 07:00 AM
RNS
Preliminary Q3 Revenue & FY Revenue Guidance
UK 100

Latest directors dealings